This is the authors' abstract. We don't add key points for this paper.
We report a case series of two patients with chronic kidney disease (CKD) who developed erythropoietin-induced pure red cell aplasia following a change in erythropoietin preparation. Both patients responded well to immunosuppressive treatments, but unfortunately developed severe infections as a result of being immunosuppressed.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Edwards et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: